ABSTRACT: Perinatal nutrition programs physiologic and metabolic functions, with consequences on the susceptibility to develop metabolic diseases in adulthood. The microbiota represents a key factor of such programming. We investigated whether perinatal prebiotic [short-chain fructooligosaccharides (scFOS)] supplementation improved adult metabolic health in association with microbiota changes in pigs used as human model. Sows were supplemented with scFOS or not during the end of gestation and the entire lactation, and offspring received scFOS accordingly during 1 mo after weaning. Pigs were then fed a standard diet for 5 mo, followed by a high-fat diet for 3 mo once adults. Perinatal scFOS supplementation induced a persistent modulation of the composition of the fecal microbiota in adulthood, notably by increasing the Prevotella genus. Meanwhile, scFOS animals displayed improved capacity to secrete glucagon-like peptide-1 and improved pancreas sensitivity to glucose without any changes in peripheral insulin sensitivity. Perinatal scFOS supplementation also increased ileal secretory IgA secretion and alkaline phosphatase activity and decreased TNF-a expression in adipose tissue. In conclusion, perinatal scFOS supplementation induced long-lasting modulation of intestinal microbiota and had beneficial consequences on the host physiology in adulthood. Our results highlight the key role of perinatal nutrition on later microbiota and host metabolic adaptation to an unbalanced diet
The developmental origins of health and disease concept, based on substantial epidemiologic evidences and experimental data (1, 2) , stipulates that adult metabolic health may be programmed by environmental factors, including nutrition, during perinatal life. The early stages of life, from the fetal life to the end of early childhood in humans (2 yr old), are a critical window of sensitivity to such programming.
The role of the microbiota in programming physiology and metabolism has recently emerged. Exposure to antibiotics in infancy, for example, has long-lasting consequences on the intestinal microbiota composition (3, 4) and on overweight and metabolic status (5) (6) (7) . The underlying mechanisms are not fully understood but may involve the known crosstalk between the microbiota and host physiology. For instance, bacterial metabolites, such as shortchain fatty acids (SCFAs), namely acetate and propionate, enhance the release of glucagon-like peptide-1 (GLP-1) by L-cells of the distal small intestine and proximal colon through the activation of the G-protein-coupled free fatty acid receptor 2 (8) . GLP-1, also termed incretin, is an intestinal hormone known to potentiate the glucose-induced insulin secretion, and interestingly, it also stimulates b-cell neogenesis and proliferation and inhibits their apoptosis, thereby increasing b-cell mass and insulin-secretion capacity (9) . This specific communication between the gut and the pancreas, which is mandatory to maintain glucose homeostasis, has been integrated under the concept of the enteroinsular axis. Intestinal microbiota, influencing this enteroinsular communication, can therefore modulate host glucose homeostasis.
The infant microbiota is shaped by early environment as delivery mode and maternal dietary habits in humans and animal models (10) (11) (12) . In fact, it is very influenced by the microbiota of its mother, from passage through the placenta and from the birth canal to breastfeeding and skin contact (13) . The favoring of the colonization of a beneficial microbiota in infancy, generating, for instance, beneficial metabolites for the host, could be a good way to promote health later in life.
Prebiotic fibers are good candidates to modulate microbiota positively. They are selectively fermented ingredients that allow specific changes of the intestinal microbiota, both in composition and metabolism, conferring benefits on the host well-being and health (14) . The impact of the consumption of a diet supplemented with prebiotics during pregnancy and lactation on offspring health has not been studied extensively but deserves attention as a result of the influence of prebiotics on microbiota composition and activity. Short-chain fructooligosaccharides (scFOS) are highly interesting prebiotic fibers, obtained from sucrose and consisting of 2-4 fructose units linked to 1 glucose molecule, which are selectively fermented by the gut microbiota, promoting growth of Lactobacillus, Bifidobacterium, Akkermensia, and Blautia coccoides mainly, as well as SCFA production (15) (16) (17) (18) . The high degree of similarity between the gut microbiota of mothers supplemented with scFOS and that of their offspring in mice, 2 wk after birth (19) , suggests that improvement of the profile of maternal gut microbiota does enhance early colonization of the offspring gut through bacterial transfer in utero, at birth, and during suckling. We previously demonstrated in pigs that maternal scFOS supplementation induced an increased fermentative activity of the offspring microbiota during lactation with a higher butyrate production after weaning (20) , compared with offspring of nonsupplemented sows. We also observed a long-lasting effect of the perinatal scFOS supplementation on microbiota metabolite production, .2 mo after the end of supplementation (21) , suggesting a persistent effect of early scFOS supplementation on microbiota composition. Consequently, it seems possible to modulate the early colonization of the gut microbiota by a maternal prebiotic supply with a persistent effect on the microbiota composition and SCFA distal gut content. However, to our knowledge, the consequences of such a microbiota modulation on the physiology and metabolism of the host have not been investigated. Our hypothesis is that the establishment of a favorable microbiota in neonates by perinatal consumption of prebiotics could have a positive impact on the developmental trajectory of the intestine and pancreas, enabling individuals to cope metabolically better with an unbalanced diet as adults. Therefore, we investigated whether perinatal scFOS supplementation could impact the gut microbiota and the host physiology, enteroinsular axis, and glucose homeostasis in adult offspring.
For such purpose, we supplemented sows with scFOS during the last third of gestation and the entire lactation and went on the supplementation of their offspring for 1 mo after weaning. Given evidence that the developmental programming effects of early nutrition can be latent, adult pigs received an unbalanced diet during 3 mo to reveal the potential effects of early scFOS supplementation on programming of their enteroinsular axis and metabolic health.
MATERIALS AND METHODS

Animals, diets, and experimental design
The experimental protocol was designed in compliance with legislations of the European Union (directive 86/609/EEC) and France (decree 2001-464 29/05/01) for the care and use of laboratory animals (agreement for animal housing number C-35-275-32). The regional Ethics Committee in Animal Experiments approved the procedure described herein (2016020217308570). Twenty-nine sows (large white 3 landrace) and their piglets [(large white 3 landrace) 3 Pietrain] from the INRA (Saint-Gilles, France) experimental herd were used in 2 replicates [n = 17 in the first replicate (R1) and n = 12 in the second replicate (R2)]. From 28 d before the presumed day of farrowing, sows were fed a standard diet (Cooperl, Lamballe, France), supplemented with either scFOS (95% of scFOS with molecular chain length between 3 and 5 monomeric units; Profeed P95; Beghin-Meiji, Marckolsheim, France; scFOS group; n = 14) or maltodextrin as a control [Maldex; Tereos Starch & Sweeteners Europe, Marckolsheim, France; control (CTRL) group; n = 15; Fig. 1 ]. Sows were given 3 kg d 21 feed during gestation and were fed ad libitum during lactation, resulting in an approximate daily intake of 10 g scFOS over the experimental gestation and lactation periods, as detailed previously (21) . Before weaning, sow-reared piglets had no access to creep feed. At weaning [postnatal day (PND) 28], piglets were fed ad libitum a commercial starter diet, supplemented with 0.15% scFOS (n = 37) or maltodextrin (CTRL; n = 42), according to the maternal diet, during 4-7 wk. This early postweaning period corresponds to the onset of food diversification in humans; this is why we decided to cover this period with scFOS supplementation too, in addition to maternal supplementation. Then, pigs were randomly selected to be used further in the experiment [n = 17 CTRL (10 from R1 and 7 from R2) and n = 18 scFOS (11 from R1 and 7 from R2)] and reared on a commercial growing diet until 6 mo of age, followed by a high-fat (HF), high-energetic diet, formulated at INRA to provide 22.6% of energy from lipids, until 9 mo of age (PND 274; Fig. 1 ). Offspring body weight was measured weekly until weaning and then every 2 wk during the supplementation period. From PND 155 (5 wk before the introduction of the HF diet), pigs were weighed weekly until the end of the experiment. Pigs were monitored daily for food intake, as well as for fever or diarrhea. No medication or antibiotic treatment was administered throughout the experimental protocol. Composition of sow diets and pig diets is provided in Supplemental Table 1 .
Fecal and blood sample collection
Fecal and blood samples were collected at different stages of development during the experiment. Fecal samples were collected from a subset of piglets at PND 21, 50, 190, 211 , and 253 to analyze microbiota composition (PND 21, n = 6 per group; PND 190, n = 6 per group; PND 253, n = 6 per group) and to determine the evolution of SCFA production (n = 7 per group and per age; Fig. 1 ). For microbiota analysis, subsamples of feces were stored immediately at 280°C after collection without any treatment, whereas for SCFA analysis, 1 ml 0.5% ortho-phosphoric acid solution per gram of feces was added, and samples were centrifuged at 1700 g for 15 min at 4°C. Supernatants were then stored at 220°C for later analysis. Blood was collected in a subset of piglets at PND 21 (n = 91 CTRL and n = 79 scFOS) and after weaning at PND 77 (n = 42 CTRL and n = 37 scFOS), PND 190 (n = 17 CTRL and n = 18 scFOS), and PND 253 (n = 17 CTRL and n = 18 scFOS) in tubes containing EDTA. After centrifugation at 2500 g for 10 min at 4°C, plasma samples were stored at 220°C for further analysis of glucose, insulin, and inflammatory marker concentrations.
16S rRNA high-throughput sequencing of fecal microbiota
Genomic DNA was extracted from feces using a QIAamp DNA Stool Mini Kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions, including a bead-beating step. PCR amplification of the V1-V3 region of the 16S rDNA and library preparation was performed as previously described (22) . In brief, PCR amplification of the V1-V3 region of the 16S rDNA and library preparation was performed with the following primers (with Illumina overhand adapters): forward (59-GAGAGTTT-GATYMTGGCTCAG-39) and reverse (59-ACCGCGGCTGCT-GGCAC-39). Each PCR product was purified with the Agencourt AMPure XP beads kit (Beckman Coulter, Pasadena, CA, USA) and submitted to a second PCR round for indexing, using the Nextera XT index primers 1 and 2. After purification, PCR products were quantified using the Quant-IT PicoGreen (Thermo Fisher Scientific, Waltham, MA, USA) and diluted to 10 ng/ml. A final quantification, by quantitative PCR, of each sample in the library was performed using the KAPA SYBR FAST qPCR Kit (Kapa Biosystems, Wilmington, MA, USA) before normalization, pooling, and sequencing on a MiSeq sequencer using v3 reagents (Illumina, San Diego, CA, USA).
The 16S rRNA gene reads were processed with the mothuR package (23) . The quality of all sequence reads was denoised using the Pyronoise algorithm implemented in mothuR and filtered with the following criteria: minimal length of 425 bp, an exact match to the barcode, and 1 mismatch allowed to the proximal primer. The sequences were checked for the presence of chimeric amplifications using Uchime. The resultant read sets were compared with a reference dataset of aligned sequences of the corresponding region derived from the SILVA database (v1.19) of full-length rRNA gene sequences implemented in mothuR (24) . The final reads were clustered into operational taxonomic units (OTUs) using the nearest neighbor algorithm using mothuR with a 0.03 distance unit cutoff. A taxonomic identity was attributed to each OTU by comparison with the SILVA database (80% homogeneity cutoff). As mothuR is not dedicated to the taxonomic assignment beyond the genus level, all unique sequences for each OTU were compared with the SILVA dataset 111 using BLASTN algorithm. For each OTU, a consensus-detailed taxonomic identification has been given based on the identity (,1% of mismatch with the aligned sequence) and the metadata associated with the best hit (validated bacterial species or not).
SCFA measurement in feces
SCFA assay was performed by gas chromatography in supernatant of ortho-phosphoric acid-treated feces as previously described (25) .
Tissue sample collection
At PND 21 and 274, 17 (n = 9 CTRL and n = 8 scFOS) and 24 (n = 11 CTRL and n = 13 scFOS) pigs, respectively, were euthanized in our experimental slaughterhouse by electrical stunning and exsanguination (Fig. 1) . After opening the intestinal cavity, portal blood was collected (PND 21) in tubes containing the dipeptidylpeptidase-IV inhibitor (10 ml/ml blood; EMD Millipore, Billerica, MA, USA) and EDTA. Figure 1 . Overview of the study design. Twenty-nine sows and their piglets were used in 2 replicates (n = 17 in R1 and n = 12 in R2). From 28 d before the presumed day of farrowing, sows were fed either a control diet (n = 15, CTRL group) or scFOSsupplemented diet (n = 14, scFOS group) until the end of the lactation. Plasma was collected in suckled piglets (n = 170) at PND 21 and in weaned pigs at PND 77 (n = 79), PND 190 (n = 35), and PND 253 (n = 35) to analyze glucose homeostasis at different stages. An IVGTT was performed at the end of the experiment at PND 267 (n = 24) to evaluate the glucose homeostasis. Fecal contents were collected at PND 21, PND 190, PND 211, and PND 253 (n = 14/age of collect) to determine the SCFA production, reflective of the fermentative activity of the microbiota. Seventeen piglets were euthanized at PND 21 to investigate the development of the enteropancreatic axis, and 24 pigs were euthanized at the adult stage to evaluate the adaptation of the enteropancreatic axis to 3 mo of the HF diet.
nodes (MLNs) were removed and placed immediately in HBSS (MilliporeSigma, Saint-Quentin Fallavier, France), supplemented with 2% fetal calf serum (FCS), 100 IU/ml penicillin, and 100 mg/ml streptomycin (MilliporeSigma) for mononuclear immune cell isolation. Ileal biopsies (with and without the Peyer's patch) were rinsed with PBS containing 1% DTT (MilliporeSigma) and 1% FCS and then placed in medium made with 74% PBS, 25% DMEM (MilliporeSigma), and 1% FCS, supplemented with 5 g/ml gentamicin (MilliporeSigma) and 1.2 mg/ml amphotericin B (MilliporeSigma) for immediate explant culture. Intestinal tissues from distal ileum (10 cm proximal to the ileocecal junction), cecum (distal part, i.e., bottom of the organ), and proximal colon (at the end of the first third of colon; PDN 21 and 274) were collected, rinsed with cold PBS, and stored at 280°C until GLP-1 extraction and assay. For later immunohistochemical analyses, samples of 1 cm 3 were dissected from cecum and from the pancreas body and fixed in 4% paraformaldehyde. Another sample of the pancreas body was collected and stored immediately at 280°C for insulin extraction. In addition, at PND 274, a 5 cm ileal segment was rinsed with cold PBS, and collected ileal lavage was stored at 220°C until secretory IgA (sIgA) analysis. Mucosa was scrapped from a 10 cm ileal segment for further intestinal alkaline phosphatase (IAP) assay. Samples of dorsal longissimus muscle and visceral and dorsal subcutaneous adipose tissue were frozen in liquid nitrogen and stored at 280°C until further molecular biology analysis.
Intravenous glucose tolerance test
At PND 253, under general anesthesia, a catheter was inserted into 1 external jugular vein of the animals (26) (n = 11 CTRL and n = 13 scFOS). One week after surgery and overnight food withdrawal, the intravenous glucose tolerance test (IVGTT) was performed, consisting in multiple blood samplings: 2 basal samples were taken at 30 and 15 min before the intravenous glucose injection (0.5 g/kg body weight) and at 0 (just after the end of glucose injection), 3, 6, 10, 15, 20, 25, 30, 35, 40, 50, 60 , and 75 min after glucose injection. Blood was collected in tubes containing EDTA (or EDTA plus a dipeptidylpeptidase-IV inhibitor, as described previously in Tissue sample collection). After centrifugation at 2500 g for 10 min at 4°C, plasma samples were stored at 220°C (or 280°C for GLP-1 assay-dedicated samples) for later analyses. Insulin and glucose assays were performed on all plasma samples. GLP-1 assays were only performed on basal samples. The incremental area under the curve (AUC) was calculated over 75 and 30 min for glucose and insulin. The acute insulin response (=mean insulin concentration above basal values for the first 6 min) and the rate of glucose disappearance (K G ; =the negative slope of the regression line obtained with the logtransformed plasma glucose values from 3 to 30 min, in percentage per minute) were also calculated. Insulin sensitivity was evaluated from fasting basal values of glucose and insulin using the homeostasis model assessment insulin-resistance index [HOMA-IR; = (basal value of glucose 3 basal value of insulin)/22.5] and by calculating the insulin-sensitivity index 2 (S 2 ), described to be well correlated to the insulin-sensitivity index obtained by the gold standard euglycemic hyperinsulinemic clamp (27) and taking into account AUC 0-30 min of insulin and K G . The glucose and insulin responses were also integrated using the minimal model, described by Bergman (28) , to obtain the insulin-sensitivity index S I , as well as the glucose efficiency index (S G ).
Hormone, glucose, lipid, and inflammatory marker assays
Insulin content was extracted from the pancreas in 20 ml ethanol acid solution (1.5% HCl 12 M, 75% absolute ethanol, 23.5% H 2 O; Polytron 3100; Kinematica, Bohemia, NY, USA; 24,000 rpm, 2 3 20 s). Insulin concentrations were measured on plasma and pancreas extracts (dilution 1:3000) by a commercially available radioimmunoassay kit using iodinated porcine insulin (Insulin-CT; Cisbio Bioassays, Codolet, France). GLP-1 content was extracted from ileal mucosa, cecum, and colon by homogenization of 1 g tissue in 5 ml ethanol acid solution (1% HCl 12 M, 74% absolute ethanol, 25% H 2 O; Polytron 3100; Kinematica; 24,000 rpm, 2 3 20 s). Then, a GLP-1 concentration was measured in plasma and intestinal samples (dilutions 1:1000, 1:200, and 1:250 for ileal mucosa, cecum, and colon, respectively) using a commercially available GLP-1 (active) ELISA kit (EMD Millipore).
Plasma glucose, nonesterified fatty acids, triglycerides, cholesterol, and haptoglobin were assessed by an automated spectrophotometric method (Konelab 20i; Thermo Fisher Scientific, Illkirsh, France) using specific commercial kits for each marker (BioMérieux, Bruz, France). Plasma LPS was measured using the porcine LPS ELISA kit (MyBioSource, San Diego, CA, USA). The concentration of bioactive phosphatase alkaline was determined in ileal mucosa with a commercial kit (Sensolyte; Anaspec, San Jose, CA, USA) using paranitrophenyl phosphate as the substrate. Alkaline phosphatase activity concentrations were expressed per milligram of soluble protein.
sIgA was measured in ileal washes. Once collected, samples of ileal washes were homogenized and centrifuged for 10 min at 4°C at 500 g, and supernatants were collected and stored at 220°C until analysis of the total sIgA level using the swine IgA ELISA Quantitation Kit (Bethyl Laboratories, Montgomery, AL, USA).
Finally, MLN cells were isolated by mechanical dissociation before purification over a density gradient (Histopaque, density of 1.077 g/ml; MilliporeSigma) and cultured for 72 h at 37°C under an atmosphere containing 5% CO 2 , as we previously described (21) . Culture of both types of ileal biopsies (with and without the Peyer's patch) were processed, as already described (29) , and incubated for 20 h. Three different conditions of culture were performed for MLN cells and biopsies: unstimulated condition, in the presence of 5 mg/ml concanavalin A [ConA; from Canavalia ensiformis (Jack bean); MilliporeSigma], or in the presence of 10 mg/ml LPS (ultrapure LPS, from Escherichia coli 0111: B4 strain; InvivoGen, Toulouse, France) for MLN cells and 25 mg/ ml LPS (from E. coli 055:B5 strain; MilliporeSigma) for biopsies. Supernatants were collected and stored at 220°C for later cytokine analysis by ELISA (R&D Systems Europe, Lille, France). Concentrations were expressed in picograms per milliliter of supernatants for MLN cells (IFN-g, TNF-a, IL-10) and picograms per milligram of tissue for explant cultures (IFN-g, TNF-a, IL-10, IL-8).
Immunohistochemical analyses
After fixation for 24 h in 4% paraformaldehyde, pancreas and cecum samples were cryoprotected overnight at 4°C in PBS containing 30% sucrose, embedded in the optimum cutting temperature compound (TissueTek; Sakura Finetek Europe, Zoeterwoude, The Netherlands), frozen in isopentane, and sectioned (10 mm) using a cryostat-microtome. Immunohistochemical analysis of pancreas was processed, as previously described (30) , to obtain the number, area of islets, and percentage of endocrine tissue. Cecum sections were incubated with PBS containing 4% normal horse serum and 0.5% Triton X-100 for 30 min. Sections were then exposed overnight to a rabbit anti-GLP-1 antibody (1:500; Abcam, Cambridge, United Kingdom). After washing with PBS, they were incubated with an anti-rabbit antibody conjugated with FITC (1:200; Jackson ImmunoResearch Laboratories, West Grove, PA, USA) for 3 h. Sections were washed again with PBS, coverslipped with Vectashield (Vector Laboratories, Burlingame, CA, USA), and examined with a fluorescence microscope (Eclipse E400; Nikon Instruments France, Champigny-Sur-Marne, France) attached to a digital camera (Digital Still DXM 1200; Nikon Instruments France). The whole section of the tissue was scanned using a digital slide scanner (Nanozoomer 2.0-RS; Hamamatsu Photonics France, Massy, France). Recorded files were analyzed using the software NDPI (Hamamatsu Photonics France) for determination of the number of GLP-1-secreting cells per area of mucosa.
RNA extraction and real-time quantitative PCR
To characterize sensitivity of peripheral tissues to insulin, we analyzed mRNA levels of GLUT-4 and insulin receptor (INSR) in long back muscle, subcutaneous and visceral adipose tissues, plus sterol regulatory element-binding transcription factor 1C (SREBP1C) in both adipose tissues-the level of these mRNA being well correlated to protein expression in these tissues (31, 32) . Total RNA from adipose tissue and muscle samples was extracted via the Trizol method (Thermo Fisher Scientific, Waltham, MA, USA). Extracted RNA samples were quantified using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). The RNA quality was verified using the Agilent RNA 6000 Nano kit and an Agilent 2100 Bioanalyzer (Agilent Technologies France, Massy, France). All samples met quality criteria. All extracted RNA exhibited an RNA Integrity Number .7. Total RNA (2 mg) was used for reverse transcription, performed according to the manufacturer protocol (High Capacity Complementary DNA Reverse Transcription Kit; Thermo Fisher Scientific, Waltham, MA, USA). Real-time PCR was performed with the StepOnePlus real-time PCR machine using SyberGreen master mix (Thermo Fisher Scientific, Waltham, MA, USA) for detection. For each primer pair, efficiencies of PCR were measured by the slope of a standard curve using serial dilutions of a pool of cDNA from the present experiment. In this experiment, they ranged from 95 to 100%, with R 2 . 0.99. The relative quantity of target gene transcripts was normalized against the geometric mean of 3 or 2 housekeeping genes and analyzed using the DDC t method (33) . In this experiment, Ribosomal Protein L4 (RPL4), Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH), and Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta (YWHAZ) were used as housekeeping genes for muscle and visceral adipose tissue samples, whereas GAPDH and Hypoxanthine phosphoribosyltransferase 1 (HPRT1) were identified as stable reference genes for subcutaneous adipose tissue samples, as they exhibit high-stability values among samples and were not significantly affected by dietary treatments (Supplemental Table 2 ). Relative quantification of genes of interest was obtained comparing the treated group (scFOS) with the untreated group (CTRL).
Statistical analysis
With the consideration of microbiota analysis, statistical differences of population abundance between groups were assessed with ANOVA, corrected for multitesting (Benjamini-Hochberg False Discovery Rate) using STAMP software (http://kiwi.cs.dal. ca/Software/STAMP) (34). Statistical differences of specific bacterial populations between the same age groups were assessed by 2-way ANOVA and Tukey-Kramer post hoc test using GraphPad Prism software (v.6.04 for Windows; GraphPad Software, La Jolla, CA, USA; www.graphpad.com). All other data, not relating to the composition of the microbiota, were subjected to ANOVA using R Core Team (2013; R Foundation for Statistical Computing, Vienna, Austria; http://www.R-project.org/). Two-way ANOVA, with diet (CTRL vs. scFOS), replicate (R1 vs. R2), and their interaction as factors, was performed for body weight, body composition, and metabolic and inflammatory parameters at each age. Adult pig body weight and energy intake during the HF diet period were subjected to ANOVA with repeated measurements, including diet (CTRL vs. scFOS), time (weeks), replicate (R1 vs. R2), and the interactions between diet and time and diet and replication. When diet effect or interaction between diet and time was significant, differences between dietary groups at each time were further measured by Tukey post hoc test. Insulin and glucose responses to IVGTT were analyzed by ANOVA with repeated measurements, including diet (CTRL vs. scFOS), time (minutes after glucose injection), replication (R1 vs. R2), and the interactions between diet and time and diet and replication, followed by Tukey post hoc test. Correlations among all parameters were evaluated using Spearman's Rho (R) test. All data are presented as means 6 SEM. Statistical significance was defined as P # 0.05, and trend was reported as P # 0.10.
RESULTS
Early scFOS supplementation did not modify body weight at any stage of development (until PND 190; Table 1 ). The HF diet did not induce any further growth differences between scFOS and CTRL pigs (Fig. 2A) . The energy intake of the HF diet decreased continuously with time, except during the first week, with a peak of energy intake ( Fig. 2B ) being higher for the scFOS group than for CTRL pigs (P = 0.02) but without differences on growth between both groups (Fig. 2A) . Moreover, scFOS pigs tended to ingest more energy during the eighth week (P = 0.07) of the HF diet (Fig. 2B) . Mean values 6 SEM. CTRL, perinatal control diet; HF, high-fat diet; PND, postnatal day; scFOS, perinatal short-chain fructooligosaccharide supplemented diet.
scFOS PROGRAM GUT MICROBIOTA AND METABOLIC HEALTH
Early scFOS intake modified fecal microbiota composition and fecal SCFA content and impacted the glucose metabolism of suckling piglets
In 21-day-old piglets nursed by sows supplemented with scFOS, the abundance of bacteria belonging to Bacteroidetes phylum was increased (P , 0.001), whereas that of bacteria from Firmicutes phylum was reduced (P , 0.001; Fig. 3A) . At the genus level, maternal scFOS supplementation induced a higher relative proportion of Prevotella (P , 0.001), Bacteroidales_unclassifed (P , 0.01), and Treponema (P , 0.001) and a reduction of Bacteroides (P , 0.001) and Ruminococcaceae_unclassified (P , 0.001; Fig. 3A) . The highest proportion of Treponema was specifically linked to 1 piglet. The fecal SCFA content was also modified with an increase in total SCFA concentration in feces of suckling piglets whose mothers received scFOS supplementation (P = 0.001; Table 2 ), more particularly, acetate, propionate, valerate, and caproate (P , 0.05). Yet, these differences in fecal SCFA concentrations were not maintained after weaning at the end of the scFOS supplementation (PND 50; Table 2 ).
Plasma insulin concentration of scFOS piglets at PND 21 was reduced (P = 0.02) with no difference in glycemia, resulting in a lower insulin/glucose ratio (P = 0.02; Table 3 ). In addition, plasma GLP-1 concentration tended to decrease at PND 21 in scFOS piglets (P = 0.09) without modulation of the density of GLP-1-secreting L-cells in the cecal part of the intestine (Table 3 ). The proportion of pancreatic endocrine tissue was significantly decreased in scFOS piglets (P = 0.01), as well as the pancreatic content of insulin (P = 0.05; Table 3 ). In addition, the macronutrient composition of sow's milk, measured 3 wk after farrowing, indicated that scFOS-supplemented sows produced milk with higher dry matter (P = 0.004), lipid (P = 0.01), and protein (P = 0.09) contents, resulting in a higher energy value (P = 0.005; Supplemental Table 3 ).
The early changes in fecal microbiota were maintained in older pigs independently of the diet At PND 190, while they were fed a standard diet, pigs from the scFOS group displayed a higher proportion of Bacteroidetes phylum (P , 0.001), as a consequence of the increase of the Prevotella genus abundance (P , 0.001; Fig.  3B ). A higher proportion of the Lachnospiraceae_unclassified genus (P , 0.001) was also observed in the scFOS group. In addition, the early scFOS supplementation induced a decrease in the proportion of Ruminococcaceae_unclassified and Bacteroidales_unclassified genuses (P , 0.05; Fig. 3B ). However, the fecal SCFA concentrations were not different between groups (P = 0.76; Table 2 ).
Three weeks after the beginning of the HF diet (at PND 211), scFOS pigs tended to display a higher acetate concentration in feces (P = 0.09), but it did not persist 6 wk later (at PND 253; Table 2 ). However, the microbiota composition differed between CTRL and scFOS groups at PND 253. Adult scFOS pigs, under an HF diet, displayed an increased proportion of Proteobacteria phylum (P , 0.01) without any changes in the 2 main phyla (Firmicutes and Bacteroidetes; Fig. 3C) . At the genus level, the proportion of Prevotella was still higher in the scFOS group (P , 0.001; Fig.  3C ). Interestingly, the Prevotella genus abundance was positively correlated to total SCFA concentration in fecal content (P , 0.05; R = 0.48).
Early scFOS supplementation programmed the enteroinsular axis and glucose metabolism in adult pigs
At PND 253, the GLP-1-secreting L-cell density in the cecum was higher (+33%) in the scFOS group compared with CTRL pigs (P = 0.03; Fig. 4A ). Concomitantly, fasting plasma GLP-1 concentration tended to increase approximately twice in the scFOS group compared with the CTRL group (P = 0.09; Fig. 4B ). Interestingly, these 2 parameters were positively correlated (P = 0.05, R = 0.47). In the pancreas, no difference was measured on the proportion of endocrine tissue (0.97 6 0.16% for CTRL and 0.96 6 0.09% for the scFOS group) nor on the insulin content (6.70 6 1.61 mUI/g for CTRL and 7.20 6 1.57 mUI/g for the scFOS group). However, the pancreatic insulin content was Plasma fasting glucose and insulin concentrations were not different between groups, neither before (PND 190) nor after the HF diet period (PND 253; Table 4 ), nor were the lipid concentrations (triglycerides, free fatty acids, and total cholesterol; data not shown). When the glucose homeostasis was challenged by an intravenous injection of glucose (IVGTT), scFOS animals secreted more insulin than CTRL animals with no difference in glucose profile (Fig. 5) . Calculated indexes from insulin and glucose profiles resulted in a tendency to a higher insulin AUC between 0 and 30 min after glucose injection in scFOS pigs (P = 0.07), as well as a reduction in S 2 (P = 0.09) and in S I (P = 0.02) indices (Table 4) 
Early scFOS intake did not modify insulin sensitivity but reduced proinflammatory cytokine expression in visceral adipose tissue
No difference in subcutaneous adiposity but an increase in visceral adipose tissue weight was noticed in scFOS pigs (P = 0.02). No other difference in relative organ weight was recorded between groups at slaughter ( Table 1 ). None of the studied genes representative of insulin sensitivity in muscle and adipose tissues displayed differences in mRNA levels between CTRL and scFOS groups at PND 273 ( Table 5) . TNF-a and IL-10 expression was not different between scFOS and CTRL animals in the subcutaneous adipose tissue, but TNF-a expression significantly decreased in the visceral adipose tissue of scFOS pigs compared with CTRL pigs (P = 0.02; Table 5 ). Plasma Figure 3 . Fecal microbiota composition analysis by 16S profiling. Mean phylotype distribution (phylum and genus levels) expressed as cumulated relative abundance mean (n = 6 per group) at PND 21 during suckling (A), PND 190 after standard diet feeding (B), and at PND 253 after a 3 mo period of HF diet feeding (C ). CTRL, perinatal control diet; scFOS, perinatal shortchain fructooligosaccharide supplemented diet; HF, high-fat. *↑↓P , 0.05 between groups at the same age. scFOS PROGRAM GUT MICROBIOTA AND METABOLIC HEALTHhaptoglobin and LPS concentrations were not modified by early scFOS supplementation ( Table 6 ).
Early scFOS intake improved intestinal protection in adult pigs
Adult scFOS pigs displayed a tendency for an increased IAP level in the ileal mucosa (P = 0.098) and a significant increase in sIgA concentration in ileal washes (P = 0.03) compared with CTRL pigs (Table 6 ). The concentration of sIgA in ileal washes was positively correlated to the IAP level (P = 0.03, R = 0.46) and negatively to the plasmatic LPS (P = 0.02, R = 20.48). In vitro stimulation of MLN cells from scFOS animals with ConA mitogen secreted more IFN-g than those from CTRL animals (P = 0.003), but there was no difference when MLN cells were stimulated with LPS ( Table 6 ). The secretion of the other measured cytokines (TNF-a and IL-10) was not different between groups (Table 6 ) in both conditions (except LPS-induced IL-10 secretion, which tended to be lower in scFOS; P = 0.06). Cytokine secretions (TNF-a, IL-10, IFN-g, and IL-8), after in vitro culture of ileal explants, with and without the Peyer's patch, were not modified by early scFOS supplementation (Supplemental Table 4 ).
DISCUSSION
Accumulating evidences suggest that nutrition during fetal and early postnatal life programs microbial, metabolic, and immune development in offspring, with later consequences on their susceptibility to metabolic diseases. We showed that scFOS supplementation, known to well balance the gut microbiota during perinatal life, programs the intestinal endocrine function with increased pancreas sensitivity to glucose in a GLP-1-dependent manner through microbiota changes, as well as the resistance to inflammation. This scFOS-induced programming may be beneficial to cope with an unbalanced diet in adulthood.
We first analyzed the microbiota and metabolic profile of suckling piglets whose mothers were supplemented with scFOS or not. Our results demonstrated that it is possible to modulate the microbiota establishment in suckling piglets by maternal scFOS supplementation during the perinatal period. Indeed, the bacterial composition of scFOS offspring displayed a higher proportion of Bacteroidetes phylum and more particularly, an increase in the Prevotella genus compared with the nonsupplemented CTRL group. Total SCFA content, notably acetate, was increased in feces of suckling scFOS piglets. This is consistent with the increase of Prevotella, known to ferment complex carbohydrates and to produce high amounts of SCFA (35) . In connection with these early microbiota modifications, the maternal scFOS supplementation induced an improvement of the glucose tolerance in suckling piglets, as the amount of insulin required to return to the basal glycemia after suckling was diminished. Maternal scFOS supplementation did not modify the intestinal endocrine function, with the same L-cell density and GLP-1 tissue content between both groups, but reduced the development of the endocrine pancreas, objectified by a reduction in endocrine tissue percentage and insulin secretion by the pancreas, in association with a tendency to a decreased plasma GLP-1 concentration. The difference of maternal milk composition, with an increase in lipid content and energy value and a tendency for more proteins with scFOS supplementation, could explain such effects. In fact, a modulation of the diet during the perinatal life (via the maternal diet or directly by the postnatal diet) can induce significant effects on endocrine pancreas development and glucose tolerance (36) (37) (38) . In addition, the lower development of endocrine pancreas, a potential consequence of a lower request of its endocrine function, could be a result of an improved insulin sensitivity of the peripheral tissues, as observed in rats fed by mothers supplemented with 21.6% of oligofructose (OF)/inulin, with an overexpression of uncoupling protein 1 and peroxisome proliferator-activated receptor-g coactivator 1a in adipose tissue (39) .
Afterward, we analyzed the programming effects of such early modifications in adulthood. There was no difference in fecal SCFA concentration between scFOS and CTRL groups after weaning or in adulthood, contrary to our previous results showing an increase butyrate content in the distal intestine in 2 (20)-and 3-mo-old pigs (21) . However, early scFOS-induced differences in microbiota composition persisted until adulthood, particularly the higher relative proportion of the Prevotella genus. Accordingly, in another study in rats, microbiota modulation in early life by maternal OF/inulin intake (21.6% from conception to weaning) induced persistent modifications with an increase of Bifidobacterium spp. and Clostridium coccoides in adult rat offspring (40) .
In association with these microbiota changes, metabolic parameters of the host were modulated by early scFOS intake. Actually, a higher fasting GLP-1 concentration in adult pigs that received early scFOS supplementation correlated to a significant increased GLP-1-secreting L-cell density in the cecum, indicating an increased capacity of the scFOS adult offspring to secrete GLP-1. Adult rats, following a perinatal OF supplementation, did not display changes in postprandial GLP-1 level but showed an increase in gastric inhibitory peptide concentration, another incretin hormone, secreted by more proximal K cells (41) . Moreover, when ingested directly by healthy adults or adults displaying deleterious metabolic conditions (as a result of an HF diet or obesity), prebiotics increased the number of intestinal GLP-1-producing L-cells, GLP-1 content, and circulating levels of GLP-1 in humans, rats, and mice (42) (43) (44) (45) (46) (47) (48) (49) , which might, in turn, improve their metabolic status (50) . SCFAs, produced by the microbiota after scFOS intake, increase the production and release of GLP-1 by enteroendocrine L-cells in the intestine and favor L-cell differentiation in crypts (47) . In our study, perinatal scFOS consumption displayed similar effects on L-cells, 7 mo after the end of supplementation. One explanation could be the maintenance over time of a favorable microbiota, notably with high fermentative activity, established during early life. This is supported by the positive correlation observed between the SCFA production and plasmatic GLP-1 concentration. Therefore, our data demonstrated a programming of the intestinal endocrine function, probably mediated by the early establishment Mean values 6 SEM. AIR, acute insulin response; AUC, area under the curve; CTRL, perinatal control diet; HOMA-IR, homeostasis model assessment of insulin resistance; K G , rate of glucose disappearance; PND, postnatal day; scFOS, perinatal short-chain fructooligosaccharide supplemented diet; S 2 and S I , insulin sensitivity indexes; S G , glucose efficiency index.
scFOS PROGRAM GUT MICROBIOTA AND METABOLIC HEALTHof a beneficial microbiota composition and fermentative activity, which persisted into adulthood.
Once released from intestinal L-cells, GLP-1 stimulates insulin secretion and has a trophic effect on the pancreas by regulating islet cell proliferation and differentiation (9) . No difference was observed in pancreatic anatomy and insulin content between scFOS and CTRL adult pigs, but the scFOS group tended to secrete more insulin in response to an intravenous glucose stimulus with no modification of the glucose profile. This increased insulin release highlighted a higher pancreas sensitivity to glucose in scFOS pigs, as they displayed no insulin resistance in their peripheral tissues. This could be a result of their higher basal GLP-1 concentration, as suggested by Chan et al. (51) , who demonstrated that the increase in doses of GLP-1 stimulated insulin release during IVGTT in mice. The positive correlation between GLP-1-secreting L-cell density and pancreatic insulin content underlies such a role of GLP-1 on pancreas insulin-secretion capacity in our study. This was in accordance with data in HF-fed diabetic mice, in which OF supplementation, during 4 wk, was efficient to reduce starvation and postprandial glycemia in association with increased levels of plasma and pancreatic insulin. These results were obtained in a GLP-1-dependent manner through an increased plasma GLP-1 concentration and total GLP-1 content in the proximal colon (44) . In our study, we did not observe changes of the glucose profile during the IVGTT, but the negative correlation seen between AUC Glucose and the GLP-1-producing L-cells supported the role of intestinal endocrine function in the regulation of glucose homeostasis. Interestingly, the observed negative correlation between Prevotella abundance and the HOMA-IR index may suggest that the increased Prevotella proportion could be a key factor to prevent development of insulin resistance.
The programming of the intestinal immune function, which is also dependent of the microbiota composition and its fermentative activity, was investigated in adult pigs. Perinatal scFOS supplementation induced a beneficial long-lasting effect on intestinal sIgA secretion and IAP concentration (higher values of both parameters in scFOS pigs), with no significant difference in plasma LPS. The expression of IAP has been shown to be controlled by the gut microbiota (52) , as well as the sIgA release in the Values are expressed as the ratio of the relative expression of the scFOS group to the CTRL group. CTRL, perinatal control diet; scFOS, perinatal short-chain fructooligosaccharide supplemented diet. intestinal lumen (53) , in accordance with the persistent microbiota modulation induced by perinatal scFOS supplementation in adulthood. The increased sIgA secretion could be linked to the modification of bacteria populations and more particularly, to the higher relative abundance of Prevotella, as suggested by Mach et al. (54) , showing a positive correlation between Prevotella and sIgA luminal concentration in weaned pigs. Intestinal sIgA secretion is essential to prevent inflammatory responses by downregulating the expression of inflammatory cytokines, such as TNF-a and IL-6 (55). Another regulator of intestinal inflammation is IAP, which controls several gut biologic processes, such as LPS detoxification, reducing its toxicity for epithelial cells, inflammation, and bacterial translocation to the lymphoid organs (56) . An increased IAP activity may help to decrease chronically plasma LPS concentration and thereby, may reduce metabolic endotoxemia, which contributes to HF diet-induced metabolic disorders (50) . Although there was no significant difference in plasma LPS, numeric values were 37% lower in scFOS pigs, and once again, TNF-a expression in their visceral adipose tissue was significantly decreased compared with CTRL pigs. Accordingly, Hallam et al. (40) showed a reduction of plasma LPS in adult rats supplemented with prebiotics in early life, linked to a higher abundance of Bifidobacterium spp., suggested to be mediated by milk oligosaccharides. In our study, maternal scFOS supplementation induced macronutrient composition differences in sow milk, which could contribute to modulate the composition and the metabolism of the microbiota colonizing the neonatal gut and consequently, their long-lasting effects (40) . Finally, there was a positive correlation between sIgA and IAP activity and a negative one between sIgA and plasma LPS concentration, underlying a possible link between these different inflammatory parameters. Overall, our data suggested that scFOS adult offspring may be more resistant to inflammation.
The pattern of growth was not affected by perinatal scFOS supplementation nor was the body weight gain during the HF challenge, even if scFOS pigs tended to ingest more energy. Both groups regulated their energy intake after the first week of HF diet transition and did not develop hyperphagia. scFOS pigs displayed an increased visceral adiposity at PND 274, but as adiposity is predominantly located in subcutaneous adipose tissue in pigs (;65%), whereas internal adiposity represents only 5% of total body fat (57) , this reflected only a very slight quantitative effect on global adiposity. It had indeed no effect on the systemic inflammatory status and on the insulin sensitivity of peripheral tissues. Interestingly, even if heavier, the visceral tissue of scFOS pigs expressed less TNF-a compared with the CTRL group. Hallam and Reimer (41) showed a reduction in the percentage of total body fat in adult rats fed an HF high-sucrose diet whose mothers had been supplemented with prebiotics. This discrepancy could be explained by a species variability but also by the higher dose of prebiotic and the different period of supplementation used in their study (21.6% during the whole gestation) compared with ours (0.33% during the last one-third of gestation and 0.15% for lactation and post weaning), as well as the different diet composition in adulthood (41) .
In summary, our study demonstrated that the intestinal endocrine function of adult pigs and their susceptibility to inflammation is submitted to a nutritional programming that may participate to the metabolic imprint. This programming is highly connected to the microbiota. These results are of high interest to understand nutritional programming in humans and thus, to develop nutritional strategies to prevent metabolic disorders. Indeed, pigs used as a model for humans are considered to be more relevant than rodents, especially because there is higher similarity in anatomy, physiology, metabolism, and microbiota between humans and pigs (58) . Among nutritional strategies, perinatal scFOS supplementation, known to well balance the microbiota durably, seems to be an interesting way to prevent metabolic disorders and susceptibility to inflammation later in life, notably when confronted with a deleterious nutritional environment.
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